Cover Image
市場調查報告書

腎透析設備:醫療設備的開發平台評估

Renal Dialysis Equipment - Medical Devices Pipeline Assessment, 2018

出版商 GlobalData 商品編碼 350915
出版日期 內容資訊 英文 317 Pages
訂單完成後即時交付
價格
Back to Top
腎透析設備:醫療設備的開發平台評估 Renal Dialysis Equipment - Medical Devices Pipeline Assessment, 2018
出版日期: 2018年05月15日 內容資訊: 英文 317 Pages
簡介

本報告提供全球腎臟透析設備的市場上主要的開發中產品 (醫療設備)與其臨床實驗的進展調查,再彙整產品特性比較分析 (臨床實驗的各進展階段) ,以及主要企業簡介及代表性產品,近來的市場動靜 (資本交易·產業聯盟等) 資訊,為您概述為以下內容。

第1章 目錄

第2章 簡介

  • 腎臟透析設備市場概要

第3章 腎臟透析設備市場:臨床實驗中的產品

  • 開發中產品:各臨床實驗階段
  • 開發中產品:各市場區隔
  • 開發中產品:各地區
  • 開發中產品:法規途徑別
  • 開發中產品:估計認證時期別
  • 開發中產品:現在進行中的臨床實驗

第4章 臨床實驗中的開發中產品:各企業

  • 腎臟透析設備的企業:各臨床實驗階段的開發中產品
  • 腎臟透析設備:各臨床實驗階段的開發中產品

第5章 腎臟透析設備市場:企業·產品概要

  • 3S BioMedical, Inc.
    • 開發中產品及進行中的臨床實驗概要
  • Advanced Dialysis Methods Ltd.
  • AngioDynamics, Inc.
  • ARISTE Medical
  • 旭化成
  • Ash Access Technology, Inc.
  • AWAK Technologies Pte Ltd
  • Baxter International Inc.
  • Blood Purification Technologies, Inc.
  • CatheNect Medical
  • Chemica Technologies, Inc.
  • Chrysalis Medical Weight Loss Clinic
  • Circuport, Inc.
  • Control Medical Technology, LLC
  • CreatiVasc Medical LLC
  • Cytograft Tissue Engineering, Inc.
  • CytoPherx, Inc.
  • Debiotech S.A.
  • DEKA Research and Development
  • Dipylon Medical AB
  • ExThera Medical LLC.
  • Fistulink Ltd.
  • Flow Forward Medical, LLC
  • Fresenius Medical Care AG & Co. KGaA
  • Fresenius Medical Care Holdings, Inc.
  • Georgia Institute of Technology
  • Glomeria Therapeutics Srl
  • Healionics Corporation
  • Laminate Medical Technologies Ltd.
  • Marvao Medical Devices Limited
  • Medtronic plc
  • Miromatrix Medical Inc.
  • Nanodialysis BV
  • NanoVasc, Inc.
  • Nicast Ltd.
  • NuVascular Technologies Inc
  • NxStage Medical, Inc.
  • PeriTec Biosciences, Ltd.
  • Phase One Medical, LLC
  • qSTAR Medical SAS
  • Quanta Fluid Solutions Ltd.
  • RenalGuard Solutions, Inc.
  • Senexis Limited (Inactive)
  • Surgical Specialties Corporation (Inactive)
  • TEI Biosciences, Inc.
  • Tengion, Inc. (Inactive)
  • University of California, San Francisco
  • University of Limerick
  • Vanderbilt University
  • Veryan Medical Limited
  • Vital Access, Corp.
  • Vivonics, Inc.
  • Vizio Medical Devices

第6章 腎臟透析設備市場:目前的趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0550EPD

GlobalData's Medical Devices sector report, "Renal Dialysis Equipment - Medical Devices Pipeline Assessment, 2018" provides an overview of Renal Dialysis Equipment currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Renal Dialysis Equipment pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Renal Dialysis Equipment under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Renal Dialysis Equipment and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry.

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Renal Dialysis Equipment under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date.

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 8
  • 1.2 List of Figures 14

2 Introduction 15

  • 2.1 Renal Dialysis Equipment Overview 15

3 Products under Development 17

  • 3.1 Renal Dialysis Equipment - Pipeline Products by Stage of Development 17
  • 3.2 Renal Dialysis Equipment - Pipeline Products by Segment 18
  • 3.3 Renal Dialysis Equipment - Pipeline Products by Territory 19
  • 3.4 Renal Dialysis Equipment - Pipeline Products by Regulatory Path 21
  • 3.5 Renal Dialysis Equipment - Pipeline Products by Estimated Approval Date 22
  • 3.6 Renal Dialysis Equipment - Ongoing Clinical Trials 23

4 Renal Dialysis Equipment - Pipeline Products under Development by Companies 24

  • 4.1 Renal Dialysis Equipment Companies - Pipeline Products by Stage of Development 24
  • 4.2 Renal Dialysis Equipment - Pipeline Products by Stage of Development 27

5 Renal Dialysis Equipment Companies and Product Overview 30

  • 5.1 Advanced Dialysis Methods Ltd. Company Overview 30
  • 5.2 Advent Access Pte Ltd Company Overview 31
  • 5.3 AngioDynamics Inc Company Overview 32
  • 5.4 Angiotech Pharmaceuticals Inc Company Overview 33
  • 5.5 Ariste Medical LLC Company Overview 34
  • 5.6 Asahi Kasei Corp Company Overview 35
  • 5.7 Ash Access Technology Inc Company Overview 37
  • 5.8 Avenu Medical, Inc. Company Overview 39
  • 5.9 AWAK Technologies Pte Ltd Company Overview 42
  • 5.10 Baxter BioScience Inc Company Overview 43
  • 5.11 Baxter Healthcare Corp Company Overview 44
  • 5.12 Baxter International Inc Company Overview 49
  • 5.13 Blood Purification Technologies, Inc. Company Overview 58
  • 5.14 Brookhaven Medical Inc Company Overview 59
  • 5.15 CatheNect Medical Company Overview 60
  • 5.16 Chemica Technologies Inc Company Overview 61
  • 5.17 Chrysalis Medical Weight Loss Clinic (Inactive) Company Overview 62
  • 5.18 Columbia University Company Overview 63
  • 5.19 CVS Health Corporation Company Overview 64
  • 5.20 Cytograft Tissue Engineering Inc (Inactive) Company Overview 65
  • 5.21 CytoPherx, Inc. Company Overview 66
  • 5.22 Debiotech SA Company Overview 69
  • 5.23 Diavantis Company Overview 72
  • 5.24 Districlass Medical SA Company Overview 75
  • 5.25 Eqalix Inc Company Overview 76
  • 5.26 ExThera Medical Corporation Company Overview 77
  • 5.27 EXUS Software Ltd Company Overview 81
  • 5.28 Fistulink Ltd. Company Overview 82
  • 5.29 Flow Forward Medical, LLC Company Overview 83
  • 5.30 Fresenius Kidney Care Company Overview 84
  • 5.31 Fresenius Medical Care AG & Co KGaA Company Overview 85
  • 5.32 Georgia Institute of Technology Company Overview 90
  • 5.33 Glomeria Therapeutics srl Company Overview 92
  • 5.34 Healionics Corporation Company Overview 94
  • 5.35 Hemotek Medical Inc Company Overview 96
  • 5.36 Indian Institute of Technology Bombay Company Overview 97
  • 5.37 InnAVasc Medical Inc Company Overview 98
  • 5.38 Laminate Medical Technologies Ltd. Company Overview 99
  • 5.39 LiberDi Ltd Company Overview 102
  • 5.40 Marvao Medical Devices Ltd Company Overview 103
  • 5.41 Medtronic plc Company Overview 104
  • 5.42 Merit Medical Systems Inc Company Overview 105
  • 5.43 NanoVasc, Inc. Company Overview 107
  • 5.44 National Research University of Electronic Technology Company Overview 108
  • 5.45 Nephros Inc Company Overview 109
  • 5.46 Nicast Ltd Company Overview 111
  • 5.47 Nikkiso Co Ltd Company Overview 112
  • 5.48 NuVascular Technologies Inc Company Overview 114
  • 5.49 NxStage Medical Inc Company Overview 116
  • 5.50 Occlutech International AB Company Overview 118
  • 5.51 Outset Medical, Inc. Company Overview 119
  • 5.52 Oxford Biomaterials Ltd Company Overview 122
  • 5.53 Peripal AG Company Overview 123
  • 5.54 Phase One Medical LLC Company Overview 124
  • 5.55 Phraxis, Inc. Company Overview 126
  • 5.56 qSTAR Medical SAS Company Overview 127
  • 5.57 Quanta Dialysis Technologies Ltd Company Overview 128
  • 5.58 Rambam Health Care Campus Company Overview 132
  • 5.59 RegenMedTX LLC Company Overview 133
  • 5.60 Senexis Limited (Inactive) Company Overview 134
  • 5.61 Silmag SA Company Overview 135
  • 5.62 Simergent LLC Company Overview 137
  • 5.63 Stent Tek Ltd Company Overview 139
  • 5.64 Thorn Technologies LLC Company Overview 140
  • 5.65 TVA Medical Inc Company Overview 141
  • 5.66 University of California San Francisco Company Overview 145
  • 5.67 University of Colorado Company Overview 147
  • 5.68 University of Rostock Company Overview 148
  • 5.69 Vanderbilt University Company Overview 149
  • 5.70 Vascular Genesis Company Overview 150
  • 5.71 Vital Access Corp Company Overview 151
  • 5.72 Vivonics, Inc. Company Overview 152
  • 5.73 Vizio Medical Devices Company Overview 153
  • 5.74 Xerem Medical Ltd Company Overview 154

6 Renal Dialysis Equipment- Recent Developments 155

  • 6.1 May 09, 2018: ICU Medical Announces First Quarter 2018 Results 155
  • 6.2 May 09, 2018: Nephros Reports First Quarter 2018 Financial Results 155
  • 6.3 May 07, 2018: Medtronic Appoints Mike Weinstein As Senior Vice President Of Strategy 156
  • 6.4 May 03, 2018: Fresenius makes excellent start to 2018, with strong sales and net income growth in constant currency 156
  • 6.5 May 03, 2018: Teleflex Reports First Quarter 2018 Results 161
  • 6.6 May 03, 2018: Fresenius Medical Care remains on track for another record year after solid first quarter 2018 164
  • 6.7 May 02, 2018: Fresenius Medical Care Announces Leadership Change in EMEA 167
  • 6.8 Apr 27, 2018: Fresenius Medical Care holds groundbreaking ceremony for new technology development center in Schweinfurt 167
  • 6.9 Apr 26, 2018: Baxter Reports First-Quarter 2018 Results And Increases Financial Outlook For Full-Year 2018 168
  • 6.10 Apr 25, 2018: Quanta Successfully Completes Pilot Treatments in France 169
  • 6.11 Apr 25, 2018: Merit Medical Reports First Quarter of 2018 Financial Results 170
  • 6.12 Apr 25, 2018: Boston Scientific Reports Financial Results For First Quarter 2018 171
  • 6.13 Apr 24, 2018: Fresenius Medical Care wins Red Dot design award for advanced bloodline system used in hemodialysis 173
  • 6.14 Apr 22, 2018: Fresenius Medical Care confirms net income growth target, adjusts 2018 revenue growth target and releases preliminary Q1 figures 173
  • 6.15 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management 174
  • 6.16 Apr 16, 2018: Nephros Announces Preliminary Financial Results For First Quarter 2018 175
  • 6.17 Apr 05, 2018: Dr. Laura Mauri to Join Medtronic as Vice President, Global Clinical Research & Analytics 175
  • 6.18 Apr 04, 2018: CVS Health Announces Plans to Focus on Kidney Care and Dialysis Treatment 176
  • 6.19 Apr 02, 2018: NanoVibronix Provides Year-End 2017 Business Update and Files 10-K 177
  • 6.20 Mar 29, 2018: AngioDynamics Reports Fiscal 2018 Third Quarter Financial Results 178
  • 6.21 Mar 23, 2018: 2017 fiscal year: B. Braun increases sales and earnings, with investments of one billion euros 179
  • 6.22 Mar 22, 2018: Fresenius starts work on new RD building in Bad Homburg 181
  • 6.23 Mar 21, 2018: Redsense blood leakage alarm in use at three of the five largest dialysis care providers in the USA, and three of the top five-ranked hospitals 182
  • 6.24 Mar 20, 2018: LiDCO Group: End of third party UK Distribution agreement 182
  • 6.25 Mar 19, 2018: ExThera Medical Announces Creation of European Subsidiary 183
  • 6.26 Mar 15, 2018: Rockwell Medical Reports Fourth Quarter and Year End 2017 Results 183
  • 6.27 Mar 13, 2018: Seven Unique NxStage Abstracts Presented During the 38th Annual Dialysis Conference 184
  • 6.28 Mar 13, 2018: Rockwell Medical Appoints Two Independent and Experienced Life Sciences Executives to Board of Directors 186
  • 6.29 Mar 02, 2018: Quanta to Present at the 38th Annual Dialysis Conference 187
  • 6.30 Mar 01, 2018: ICU Medical Announces Fourth Quarter and Fiscal Year 2017 Results 187
  • 6.31 Mar 01, 2018: Poly Medicure: Commencement of Commercial Production 188
  • 6.32 Feb 26, 2018: Robert Ward, CEO of ExThera Medical, Elected to Prestigious National Academy of Engineering 188
  • 6.33 Feb 26, 2018: Nephros Reports 2017 Fourth Quarter and Full Year Financial Results and Provides Corporate Update 189
  • 6.34 Feb 26, 2018: Fresenius Medical Care achieves record results in 2017 and targets strong net income growth in 2018 190
  • 6.35 Feb 26, 2018: Fresenius remains on growth course after 14 straight record years 194
  • 6.36 Feb 26, 2018: Fresenius Medical Care establishes provision of EUR 200 million regarding ongoing FCPA settlement negotiations 199
  • 6.37 Feb 22, 2018: Next Step Bionics & Prosthetics Fits LUKE Arm to Do More for More People 200
  • 6.38 Feb 22, 2018: Teleflex Reports Fourth Quarter and Full Year 2017 Results; Provides 2018 Guidance 201
  • 6.39 Feb 20, 2018: NICE Updates Medical Technologies Guidance on PleurX Peritoneal Catheter Drainage System 203
  • 6.40 Feb 15, 2018: Spectral Announces Health Canada Approval of Its Proprietary Stand-Alone Pump for CRRT and Hemoperfusion 204
  • 6.41 Feb 13, 2018: Four start-ups chosen for the B. Braun Accelerator Program 205
  • 6.42 Feb 08, 2018: Redsense signs distribution agreement for Singapore with initial evaluation at Singapore General Hospital 205
  • 6.43 Feb 08, 2018: Artificial kidney development advances, thanks to collaboration by NIBIB Quantum grantees 206
  • 6.44 Feb 02, 2018: Redsense Medical: Hospital in Scotland first in the world to install Redsense blood leakage alarm that shuts off the blood flow automatically 208
  • 6.45 Feb 01, 2018: Meta-Analysis Demonstrates Positive Clinical Experience Using everlinQ endoAVF System For Hemodialysis Access 208
  • 6.46 Feb 01, 2018: Boston Scientific Announces Results for Fourth Quarter and Full Year 2017 209
  • 6.47 Feb 01, 2018: Baxter Reports 2017 Fourth-Quarter and Full-Year Results 211
  • 6.48 Jan 30, 2018: Alex Gu Named Senior Vice President and President of Medtronic's Greater China Region 214
  • 6.49 Jan 25, 2018: ExThera Medical's 'Seraph' Blood Filter Successfully Completes Pre-Clinical Testing in Final Phase of DARPA's DLT Program 214
  • 6.50 Jan 18, 2018: Laminate Medical Technologies announces enrollment of first patients in pivotal trial of the VasQ device 215
  • 6.51 Jan 18, 2018: Baxter recalls one lot of DIANEAL peritoneal dialysis solution due to the potential presence of particulate matter 216
  • 6.52 Jan 18, 2018: B. Braun to Showcase Comprehensive Parenteral Nutrition Program, New Compounder and More at ASPEN 217
  • 6.53 Jan 09, 2018: Boston Scientific Announces Preliminary Unaudited Sales For The Fourth Quarter And Full Year Ended December 31, 2017 218
  • 6.54 Jan 04, 2018: AngioDynamics Reports Fiscal 2018 Second Quarter Financial Results 218
  • 6.55 Jan 04, 2018: Nephros Announces Preliminary Financial Results for Fourth Quarter 2017 219
  • 6.56 Jan 02, 2018: Teleflex Completes Previously Announced CEO Transition 220

7 Appendix 313

  • 7.1 Methodology 313
  • 7.2 About GlobalData 316
  • 7.3 Contact Us 316
  • 7.4 Disclaimer 316

List of Tables

1.1 List of Tables

  • Table 1: Renal Dialysis Equipment - Pipeline Products by Stage of Development 18
  • Table 2: Renal Dialysis Equipment - Pipeline Products by Segment 19
  • Table 3: Renal Dialysis Equipment - Pipeline Products by Territory 20
  • Table 4: Renal Dialysis Equipment - Pipeline Products by Regulatory Path 22
  • Table 5: Renal Dialysis Equipment - Pipeline Products by Estimated Approval Date 23
  • Table 6: Renal Dialysis Equipment - Ongoing Clinical Trials 24
  • Table 7: Renal Dialysis Equipment Companies - Pipeline Products by Stage of Development 25
  • Table 8: Renal Dialysis Equipment - Pipeline Products by Stage of Development 28
  • Table 9: Advanced Dialysis Methods Ltd. Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 10: Vibro-Care - Product Status 31
  • Table 11: Vibro-Care - Product Description 31
  • Table 12: Advent Access Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 13: av-Guardian - Product Status 32
  • Table 14: av-Guardian - Product Description 32
  • Table 15: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 16: Next Generation Dialysis Device - Product Status 33
  • Table 17: Next Generation Dialysis Device - Product Description 33
  • Table 18: Angiotech Pharmaceuticals Inc Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 19: 5-FU Anti-Infective HemoStream Dialysis Catheter - Product Status 34
  • Table 20: 5-FU Anti-Infective HemoStream Dialysis Catheter - Product Description 34
  • Table 21: Ariste Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 22: Drug Eluting Tunneled Dialysis Catheter - Product Status 35
  • Table 23: Drug Eluting Tunneled Dialysis Catheter - Product Description 35
  • Table 24: Asahi Kasei Corp Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 25: APS Polysulfone-membrane Artificial Kidney - New Version - Product Status 36
  • Table 26: APS Polysulfone-membrane Artificial Kidney - New Version - Product Description 36
  • Table 27: Hemodialysis Equipment - Product Status 37
  • Table 28: Hemodialysis Equipment - Product Description 37
  • Table 29: Ash Access Technology Inc Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 30: MaxFlow - Product Status 38
  • Table 31: MaxFlow - Product Description 38
  • Table 32: SureFlow - Product Status 39
  • Table 33: SureFlow - Product Description 39
  • Table 34: Avenu Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 35: Ellipsys Vascular Access System - Product Status 40
  • Table 36: Ellipsys Vascular Access System - Product Description 40
  • Table 37: Avenu Medical, Inc. - Ongoing Clinical Trials Overview 41
  • Table 38: Ellipsys Vascular Access System - Ellipsys Vascular Access System Registry, Protocol 1.0. Version 1.0 42
  • Table 39: AWAK Technologies Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 40: AWAK - Product Status 43
  • Table 41: AWAK - Product Description 43
  • Table 42: Baxter BioScience Inc Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 43: PRISMAX V2 - Product Status 44
  • Table 44: PRISMAX V2 - Product Description 44
  • Table 45: Baxter Healthcare Corp Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 46: THERANOVA Dialyser - Product Status 45
  • Table 47: THERANOVA Dialyser - Product Description 45
  • Table 48: Baxter Healthcare Corp - Ongoing Clinical Trials Overview 46
  • Table 49: THERANOVA Dialyser - A Randomized Study Investigating the Effect of Medium Cut-off Haemodialysis on Markers of Vascular Health Compared With On-Line HDF 47
  • Table 50: THERANOVA Dialyser - Cardiovascular Risk Comparison Between Expanded Hemodialysis Using Theranova and On-line Hemodiafiltration - Exploratory, Multicenter, Randomized Clinical Trial 47
  • Table 51: THERANOVA Dialyser - Characterization of Proteins and Forms of Albumin Removal Capacities of the Theranova Membrane by Innovating Proteomic Investigations 47
  • Table 52: THERANOVA Dialyser - Evaluation of Effectiveness, Safety and Health-related Quality of Life Associated with HDx Therapy Enabled by THERANOVA in Subjects with End-stage Renal Disease: A Colombian Study 48
  • Table 53: THERANOVA Dialyser - Expanded Hemodialysis Versus Online Hemodiafiltration: A Pilot Study on Intradialytic Hemodynamics and Fluid Status 48
  • Table 54: THERANOVA Dialyser - Medium-term Modulation of the Inflammatory Profile by Medium-cut Off Membranes in Patients with End Stage Renal Disease 48
  • Table 55: THERANOVA Dialyser - Molecular and Cellular Mechanism of Vascular Ageing in Chronic Kidney Disease: Role of Theranova Dialyzer on Mineral Metabolism Disorder, Oxidative Stress, and Vascular Calcification 49
  • Table 56: THERANOVA Dialyser - Multi-center, Prospective, Randomized Controlled Study in US to Evaluate the Effectiveness and Safety of THERANOVA 49
  • Table 57: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 50
  • Table 58: AK98 Hemodialysis System - Product Status 50
  • Table 59: AK98 Hemodialysis System - Product Description 51
  • Table 60: Amia Automated PD System With Sharesource - Home Use - Product Status 51
  • Table 61: Amia Automated PD System With Sharesource - Home Use - Product Description 51
  • Table 62: Artis Dialysis System - Product Status 52
  • Table 63: Artis Dialysis System - Product Description 52
  • Table 64: Next Gen ICHD Monitor - Product Status 52
  • Table 65: Next Gen ICHD Monitor - Product Description 53
  • Table 66: Non PVC CAPD - Product Status 53
  • Table 67: Non PVC CAPD - Product Description 53
  • Table 68: oXiris - Product Status 53
  • Table 69: oXiris - Product Description 54
  • Table 70: PrisMAX V1 - Product Status 54
  • Table 71: PrisMAX V1 - Product Description 54
  • Table 72: VIVIA Hemodialysis System - Product Status 55
  • Table 73: VIVIA Hemodialysis System - Product Description 55
  • Table 74: Baxter International Inc - Ongoing Clinical Trials Overview 56
  • Table 75: VIVIA Hemodialysis System - Sleep Disturbance in Patients with End-stage Renal Disease 57
  • Table 76: VIVIA Hemodialysis System - U.S. Clinical Trial for VIVIA Investigational Home Hemodialysis System 57
  • Table 77: oXiris - Comparing Cytokines, Toxins Adsorbing oXiris Filter to ST150 Filter During CRRT in Patients with Septic Shock 58
  • Table 78: oXiris - Increased Adsorption Membranes During Cardiopulmonary Bypass. A Randomized Controlled Trial to Evaluate Impact in Postsurgical Acute Kidney Injury 58
  • Table 79: Blood Purification Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 59
  • Table 80: Wearable Artificial Kidney - Product Status 59
  • Table 81: Wearable Artificial Kidney - Product Description 59
  • Table 82: Brookhaven Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 83: Hemoaccess Valve System - Product Status 60
  • Table 84: Hemoaccess Valve System - Product Description 60
  • Table 85: CatheNect Medical Pipeline Products & Ongoing Clinical Trials Overview 61
  • Table 86: Peritoneal Dialysis Catheter - Product Status 61
  • Table 87: Peritoneal Dialysis Catheter - Product Description 61
  • Table 88: Chemica Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 89: Portable Hemodialysis System - Product Status 62
  • Table 90: Portable Hemodialysis System - Product Description 62
  • Table 91: Chrysalis Medical Weight Loss Clinic (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 92: Hemodialysis Catheter - Product Status 63
  • Table 93: Hemodialysis Catheter - Product Description 63
  • Table 94: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 64
  • Table 95: Hemodialysis Access Flow Restrictor Device - Product Status 64
  • Table 96: Hemodialysis Access Flow Restrictor Device - Product Description 64
  • Table 97: CVS Health Corporation Pipeline Products & Ongoing Clinical Trials Overview 65
  • Table 98: Home Hemodialysis Device - Product Status 65
  • Table 99: Home Hemodialysis Device - Product Description 65
  • Table 100: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 101: Lifeline TEBV - AV Shunt - Product Status 66
  • Table 102: Lifeline TEBV - AV Shunt - Product Description 66
  • Table 103: CytoPherx, Inc. Pipeline Products & Ongoing Clinical Trials Overview 67
  • Table 104: Selective Cytopheretic Device - Product Status 67
  • Table 105: Selective Cytopheretic Device - Product Description 67
  • Table 106: CytoPherx, Inc. - Ongoing Clinical Trials Overview 68
  • Table 107: Selective Cytopheretic Device - A Multi-center, Pilot Study to Assess the Safety and Efficacy of a Selective Cytopheretic Device (SCD) in Pediatric Patients with Acute Kidney Injury (AKI) 69
  • Table 108: Debiotech SA Pipeline Products & Ongoing Clinical Trials Overview 70
  • Table 109: DialEase - Product Status 70
  • Table 110: DialEase - Product Description 71
  • Table 111: Miniaturized Home Hemodialysis Machine - Product Status 71
  • Table 112: Miniaturized Home Hemodialysis Machine - Product Description 71
  • Table 113: Renal Expres - Product Status 72
  • Table 114: Renal Expres - Product Description 72
  • Table 115: Diavantis Pipeline Products & Ongoing Clinical Trials Overview 73
  • Table 116: Vivaxs Liva - Product Status 73
  • Table 117: Vivaxs Liva - Product Description 73
  • Table 118: Diavantis - Ongoing Clinical Trials Overview 74
  • Table 119: Vivaxs Liva - Bone Anchored Port - A Novel Vascular Access for Hemodialysis Treatment 75
  • Table 120: Districlass Medical SA Pipeline Products & Ongoing Clinical Trials Overview 76
  • Table 121: DIALCAN - Product Status 76
  • Table 122: DIALCAN - Product Description 76
  • Table 123: Eqalix Inc Pipeline Products & Ongoing Clinical Trials Overview 77
  • Table 124: RenalEase - Product Status 77
  • Table 125: RenalEase - Product Description 77
  • Table 126: ExThera Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview 78
  • Table 127: Seraph 100 - Product Status 78
  • Table 128: Seraph 100 - Product Description 78
  • Table 129: Seraph 200 - Product Status 79
  • Table 130: Seraph 200 - Product Description 79
  • Table 131: ExThera Medical Corporation - Ongoing Clinical Trials Overview 80
  • Table 132: Seraph 100 - Safety and Performance Evaluation of the Seraph 100 Microbind Affinity Blood Filter for Reducing Bacteremia in Patients on Hemodialysis 81
  • Table 133: EXUS Software Ltd Pipeline Products & Ongoing Clinical Trials Overview 82
  • Table 134: NEPHRON+ Wearable Artificial Kidney Device - Product Status 82
  • Table 135: NEPHRON+ Wearable Artificial Kidney Device - Product Description 82
  • Table 136: Fistulink Ltd. Pipeline Products & Ongoing Clinical Trials Overview 83
  • Table 137: Fistulink Device - Product Status 83
  • Table 138: Fistulink Device - Product Description 83
  • Table 139: Flow Forward Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 84
  • Table 140: AFE System - Product Status 84
  • Table 141: AFE System - Product Description 84
  • Table 142: Fresenius Kidney Care Pipeline Products & Ongoing Clinical Trials Overview 85
  • Table 143: Portable Artificial Kidney - Product Status 85
  • Table 144: Portable Artificial Kidney - Product Description 85
  • Table 145: Fresenius Medical Care AG & Co KGaA Pipeline Products & Ongoing Clinical Trials Overview 86
  • Table 146: Hospital Renal Replacement Device - Product Status 86
  • Table 147: Hospital Renal Replacement Device - Product Description 87
  • Table 148: Mobile Home Hemodialysis device - Product Status 87
  • Table 149: Mobile Home Hemodialysis device - Product Description 87
  • Table 150: Peritoneal Dialysis Cycler - Product Status 88

List of Figures

1.2 List of Figures

  • Figure 1: Renal Dialysis Equipment - Pipeline Products by Stage of Development 18
  • Figure 2: Renal Dialysis Equipment - Pipeline Products by Segment 19
  • Figure 3: Renal Dialysis Equipment - Pipeline Products by Territory 20
  • Figure 4: Renal Dialysis Equipment - Pipeline Products by Regulatory Path 22
  • Figure 5: Renal Dialysis Equipment - Pipeline Products by Estimated Approval Date 23
  • Figure 6: Renal Dialysis Equipment - Ongoing Clinical Trials 24
Back to Top